Related Experiment Videos
Monocyte-derived dendritic cells: development of a cellular processor for clinical applications
B Goxe1, N Latour, J Bartholeyns
1ImmunoDesigned Molecules, Paris.
Research in Immunology
|December 16, 1998
Summary
This study presents a standardized method for generating clinical-grade dendritic cells (DCs) from human monocytes. The developed process ensures the quality and functionality of these MAC-DCs for potential therapeutic applications.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Dendritic cells (DCs) are professional antigen-presenting cells with significant clinical potential.
- Existing methods for DC generation require optimization for standardized clinical use.
Purpose of the Study:
- To develop and standardize an ex vivo process for generating clinical-quality dendritic-like cells (MAC-DCs) from human monocytes.
- To characterize the phenotype and function of the generated MAC-DCs.
Main Methods:
- Human monocytes or mononuclear cells were cultured in AIM-V medium with GM-CSF and IL-13 in non-adherent bags.
- Quality control included bacterial sterility, viability, morphology, and recovery assessments.
- Phenotypic analysis used flow cytometry for markers like CD14, CD64, MHC-I, MHC-II, CD40, CD80, CD86, CD83, and CD1a.
Main Results:
- The process yielded viable, sterile, and morphologically consistent MAC-DCs.
- MAC-DCs exhibited an immature phenotype with appropriate expression of key surface markers.
- Generated MAC-DCs effectively stimulated allogeneic T-cell proliferation and autologous memory T-lymphocyte responses to recall antigens.
- Enhanced phagocytic activity against yeast, tumor cells, and debris was observed.
Conclusions:
- A reproducible, closed-system process (Vac Cell Processor) for GMP-compliant production of clinical-grade MAC-DCs has been optimized.
- The developed method provides a robust platform for generating functional dendritic cells for immunotherapeutic applications.